Development code · Small Molecule
NW-3509
NW-3509 is a development code for Evenamide, developed by Newron Pharmaceuticals S.p.A..
- Status
- Phase 3 for Schizophrenia
- Mechanism
- Presynaptic glutamate release (voltage-gated Na+ channels) Inhibitor
- Developer
- Newron Pharmaceuticals S.p.A.
Programs
- Evenamide for SchizophreniaPhase 3Active
Also known as
- NW-3509A
- evenamide
- 1092977-61-1
- 2-[[2-(3-butoxyphenyl)ethyl]amino]-N,N-dimethylacetamide